Skip to main content
Clinical Trials/NCT04088708
NCT04088708
Active, not recruiting
Not Applicable

Role of Gut Microbe Composition in Psychosocial Symptom Response to Exercise Training in Breast Cancer Survivors (ROME Study)

University of Alabama at Birmingham1 site in 1 country126 target enrollmentJanuary 17, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
University of Alabama at Birmingham
Enrollment
126
Locations
1
Primary Endpoint
Composition of gut microbiota as measured by fecal samples
Status
Active, not recruiting
Last Updated
7 months ago

Overview

Brief Summary

The primary goal of this project is to determine the effects of exercise on the gut microbiome in breast cancer survivors and determine how these changes may relate to psychosocial symptoms such as fatigue.

Detailed Description

Cancer survivors are at increased risk of gut bacteria communities that can negatively impact health and energy level and it is possible that exercise can cause healthy changes in these communities. Through careful design, this study will use a controlled-feeding diet and 10 weeks of exercise training to determine exercise effects on the number, distribution, and types of bacteria in the gut of breast cancer survivors. These changes will then be linked to fatigue and physiologic effects of exercise to determine how the information can be used to enhance exercise benefits and identify new treatment strategies leveraging changes in gut bacteria communities.

Registry
clinicaltrials.gov
Start Date
January 17, 2020
End Date
August 31, 2026
Last Updated
7 months ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Laura Q. Rogers, MD, MPH

Principal Investigator

University of Alabama at Birmingham

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Composition of gut microbiota as measured by fecal samples

Time Frame: 15 weeks after baseline

Using standard diversity and taxa comparison metrics

Secondary Outcomes

  • Autonomic nervous system measured through non-invasive ECG(15 weeks after baseline)
  • Systemic inflammation tested via biomarkers(10 weeks after baseline)
  • Systemic inflammation tested via blood biomarkers(15 weeks after baseline)
  • Concentration of cortisol measured through hair sample(15 weeks after baseline)
  • Fatigue measured through fatigue specific questionnaire(15 weeks after baseline)

Study Sites (1)

Loading locations...

Similar Trials